Skip to main content

Brief Resolved Unexplained Event Clinical Pathway — Higher Risk Patient — Emergency

Brief Resolved Unexplained Event Clinical Pathway — Emergency and Inpatient

Higher-risk Infant and Considerations for Management

Higher-risk Criteria
  • Age ≤ 60 days
  • Gestational age
    • Born < 32 wks gestation or corrected gestational age < 45 wks
  • CPR by trained medical provider
  • Event lasted > 1 min
  • Recurring events
  • Abnormal (different from baseline) exam for infant
  • Concerning history: e.g., family history of sudden death, or infant death, concerning social, feeding, or respiratory-related history
Considerations for Management
  • Rationale
    In recent multi-center studies, > 80% of all cases of BRUE met higher risk criteria. Serious underlying diagnoses and recurrent events remain unusual among higher-risk cohorts as well.
  • Initial Evaluation
    Aims to detect diagnoses that need immediate treatment or intervention to prevent repeat events.
  • Secondary Evaluation
    Includes additional recommendations to determine causes for repeat events.
  • Initial evaluation may include:
    Continuous pulse ox and cardiac monitor
  • Social work screening if any concern for safety or family support
  • Feeding evaluation if event related to feeding
  • Diagnostic testing, as indicated
    • Electrocardiogram
    • Rapid viral respiratory panel or appropriate viral testing
    • Pertussis test in under-immunized and/or exposed patient
    • Complete blood count, basic metabolic panel, blood glucose, venous blood gas, lactic acid
  • Secondary evaluation if no other diagnosis made:
    Further testing during hospitalization or in outpatient setting as appropriate
  • Testing may include:
  • Continuous prolonged pulse ox and cardiac monitor
  • Observation for repeat events
  • Clinical swallow evaluation and feeding consultation
  • Other interventions to consider
    • Videofluoroscopic swallow study
    • Subspecialty consultation
      • Gastrointestinal, Otolaryngology, Pulmonary, Neurology, Cardiology, Biochemical Genetics/Metabolism
    • Comprehensive polysomnography
    • CT or MRI of head
    • Extended electroencephalogram
    • Ammonia, CHOP urine drug screen, Hospital of the University of Pennsylvania urine Drug Analysis and Pain Management Panel, and/or serum ethanol

Reference

A Framework for Evaluation of the Higher-Risk Infant After a Brief Resolved Unexplained Event  

 

Jump back to top